Health
CureVac starts clinical trial for COVID-19 vaccine candidate – Reuters India
German biotech firm CureVac has enrolled the first participant for a Phase 2b/3 clinical trial of its COVID-19 vaccine candidate, it said on Monday.
By Reuters Staff
FILE PHOTO: A vaccination against the coronavirus disease (COVID-19) from German biotechnology company CureVac is ready to use at the start of a clinical test series in the tropical institute of the university clinic in Tuebingen, Germany, June 22, 2020. REUTERS/Kai Pfaffenbach
BERLIN (Reuters) -German biotech firm CureVac has enrolled the first participant for a Phase 2b/3 clinical trial of its COVID-19 vaccine candidate, it said on Monday.
The trial, which is relevant for regulatory…
-
General22 hours agoForget a tariff-induced recession, Australians have been in recession for two years
-
Noosa News23 hours agoQueensland Opposition accuses government of ‘covering up’ Callide Power Station explosion
-
General1 hour agoWondering about winter | The Spectator Australia
-
Noosa News22 hours agoMan dies after slamming stolen car into another vehicle on rural Queensland highway